Novartis India Limited (NSE:NOVARTIND)
India · Delayed Price · Currency is INR 1,050.70
+14.10 (1.36%)
May 6, 2026, 3:29 PM IST
Novartis India Market Cap
Novartis India has a market cap or net worth of 25.94 billion as of May 6, 2026. Its market cap has increased by 33.65% in one year.
Market Cap
25.94B
Enterprise Value
19.81B
Revenue
3.48B
Ranking
n/a
PE Ratio
26.68
Stock Price
1,050.70
Market Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 25.94B, an increase of 106.13%. That is a compound annual growth rate of 2.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 25.63B | 33.26% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 46.42B |
| Innova Captab | 43.04B |
| RPG Life Sciences | 37.96B |
| Orchid Pharma | 31.74B |
| Solara Active Pharma Sciences | 23.88B |
| Indoco Remedies | 19.34B |
| Windlas Biotech | 17.95B |
| Jagsonpal Pharmaceuticals | 14.12B |